24 related articles for article (PubMed ID: 1801)
1. Concepts for biologically active peptides.
Kastin AJ; Pan W
Curr Pharm Des; 2010 Oct; 16(30):3390-400. PubMed ID: 20726835
[TBL] [Abstract][Full Text] [Related]
2. Brain Activation by Peptide Pro-Leu-Gly-NH(2) (MIF-1).
Khan RS; Yu C; Kastin AJ; He Y; Ehrensing RH; Hsuchou H; Stone KP; Pan W
Int J Pept; 2010; 2010():. PubMed ID: 20721355
[TBL] [Abstract][Full Text] [Related]
3. Influence of three short-chain peptides (alpha-MSH, MSH/ACTH 4-10, MIF-I on) dimensional attention.
Beckwith BE; Sandman CA; Kastin A
Pharmacol Biochem Behav; 1976; 5(Suppl 1):11-6. PubMed ID: 13409
[TBL] [Abstract][Full Text] [Related]
4. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
5. Hormonal influences of the extinction of conditioned taste aversion.
Rigter H; Popping A
Psychopharmacologia; 1976 Apr; 46(3):255-61. PubMed ID: 7799
[TBL] [Abstract][Full Text] [Related]
6. Interaction of alpha-MSH and MIF-I with amphetamine on open-field behavior of rats.
Sandman CA; Kastin AJ
Pharmacol Biochem Behav; 1978 Dec; 9(6):759-62. PubMed ID: 34173
[No Abstract] [Full Text] [Related]
7. Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas.
Kostrzewa RM; Kastin AJ; Spirtes MA
Pharmacol Biochem Behav; 1975; 3(6):1017-23. PubMed ID: 4815
[TBL] [Abstract][Full Text] [Related]
8. Increased acquisition of a complex appetitive task after MSH and MIF.
Stratton LO; Kastin AJ
Pharmacol Biochem Behav; 1975; 3(5):901-4. PubMed ID: 1801
[TBL] [Abstract][Full Text] [Related]
9. Neurological effects of MIF-1, MSH, and opiate peptides in clinical studies.
Kastin AJ; Ehrensing RH; Olson RD; Coy DH
Int J Neurol; 1980; 14(2-4):205-9. PubMed ID: 6152908
[No Abstract] [Full Text] [Related]
10. CNS and pituitary effects of hypothalamic peptides and MSH.
Kastin AJ; Miller LH; Sandman CA; Schally AV; Plotnikoff NP
Essays Neurochem Neuropharmacol; 1977; 1():139-76. PubMed ID: 30623
[TBL] [Abstract][Full Text] [Related]
11. Cellular mechanisms controlling melanophore stimulating hormone (MSH) release.
Hadley ME; Hruby VJ; Bower A
Gen Comp Endocrinol; 1975 May; 26(1):24-35. PubMed ID: 236974
[No Abstract] [Full Text] [Related]
12. CNS effects of peripherally administered brain peptides.
Kastin AJ; Olson RD; Schally AV; Coy DH
Life Sci; 1979 Jul; 25(5):401-14. PubMed ID: 39214
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
